This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Free Online Activities

An Update on MAOIs: Dietary Restrictions and Drug Interactions

David A. Flockhart, MD, PhD

Published: December 15, 2012

Article Abstract

Food and drug interactions with monoamine oxidase inhibitors (MAOIs) can lead to serious adverse effects, including hypertensive crisis and serotonin syndrome. Newer MAOIs that are selective and reversible or that have non-oral delivery methods may lower these risks and, thus, make MAOIs a possible choice of treatment for patients with depression.

See the entire activity.


 

Related Articles

Volume: 73

Quick Links: Side Effects-Medication , Weight

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...